Effect of constant magnetic field on the osteopontin gene expression in rat aorta smooth muscle cells

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 11, Issue 48, 2007, Pages 9805-9808

  Hu, Tao ^a,c   Zhou, Lian ^a   Jie, Wan Qi ^b   Wang, Hai Chang ^c   Yu, Zhen Tao ^a   Li, Zheng Xian ^b   Li, Huan ^c   Yang, Zhi Jun ^b  

^a NORTHWEST INSTITUTE FOR NONFERROUS METAL RESEARCH   (China)

^b NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OSTEOPONTIN;

ANIMAL CELL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; IN VITRO STUDY; MAGNETIC FIELD; MALE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZATION; RAT; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

EID: 38349122429     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Schofer J, Schluter M. Coronary restenosis after implantation of drug-eluting stents. Minerva Cardioangiol 2005;53(1)43-48
2. Cho SW, Jeon O, Lim JE, et al. Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow-derived cells and a hybrid biodegradable polymer scaffold. J Vasc Surg 2006;44 (6):1329-1340
3. Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 2006;98(7):905-912
4. Renault MA, Jalvy S, Potier M, et al. UTP induces osteopontin expression through a coordinate action of NfkappaB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells. J Biol Chem 2005;280(4):2708-2713
5. Nakamura H, Honda H, Inada Y, et al. Osteopontin expression in vascular smooth muscle cells in patients with end-stage renal disease. Ther Apher Dial 2006;10(3):273-277
6. Giachelli CM, Speer MY, Li X, et al. Regulation of vascular calcification: roles of phosphate and osteopontin. Circ Res 2005;96(7):717-722
7. Standal T, Hjorth-Hansen H, Rasmussen T. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica 2004;89(2):174-182
8. Hu T, Jia GL, Lü AL, et al. The adjusting effect of static magnetic field on the proliferation of human umbilical vein endotheliall cells. Zhongguo Linchuang Kangfu 2003;7(9):1376-1377
9. Liu CJ, Kong W, Xu K, et al. ADAMTS-12 associates with and degrades cartilage oligomeric matrix protein. J Biol Chem 2006;281 (23): 15800-15808
10. Giachelli C, Bae N, Lombardi D. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun 1991;177(2):867-873
11. Baldini V, Mastropasqua M, Francucci CM, et al. Cardiovascular disease and osteoporosis. J Endocrinol Invest 2005;28(10 Suppl):69-72
12. Shimizu H, Takahashi M, Takeda S, et al. Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation. Transplantation 2004;77(11):1661-1667
13. Ohsuzu F. The roles of cytokines, inflammation and immunity in vascular diseases. J Atheroscler Thromb 2004;11(6):313-321
14. Kato R, Momiyama Y, Ohmori R, et al. High plasma levels of osteopontin in patients with restenosis after percutaneous coronary intervention. Arterioscler Thromb Vasc Biol 2006;26(1):e1-e2
15. Kurata M, Okura T, Watanabe S, et al. Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin Sci (Lond) 2006;111(5):319-324
16. Lee JS, Basaiyga DM, Simionescu A, et al. Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses. Am J Pathol 2006;168(2):490-498
17. Schoenhagen P. Osteopontin, coronary calcification, and cardiovascular events: future diagnostic and therapeutic targets for disease prevention? Eur Heart J 2006 27(7):766-767
18. Jono S. Osteopontin and atherosclerosis. Nippon Rinsho 2005;63 Suppl 10:635-640
19. Angelucci A, Festuccia C, Gravina GL, et al. Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells. Prostate 2004;59(2):157-166
20. Zmyslon M. Biophysical mechanisms of electromagnetic fields interaction and health effects. Med Pr 2006;57(1):29-39